Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts
出版年份 2023 全文链接
标题
Dulaglutide Protects Mice against Diabetic Sarcopenia-Mediated Muscle Injury by Inhibiting Inflammation and Regulating the Differentiation of Myoblasts
作者
关键词
-
出版物
International Journal of Endocrinology
Volume 2023, Issue -, Pages 1-10
出版商
Hindawi Limited
发表日期
2023-08-08
DOI
10.1155/2023/9926462
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dulaglutide provides protection against sepsis-induced lung injury in mice by inhibiting inflammation and apoptosis
- (2023) Yue Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Nampt activator P7C3 ameliorates diabetes and improves skeletal muscle function modulating cell metabolism and lipid mediators
- (2022) Ravikumar Manickam et al. Journal of Cachexia Sarcopenia and Muscle
- Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations
- (2022) Calvin Ke et al. Nature Reviews Endocrinology
- Amelioration of inflammatory myopathies by glucagon‐like peptide‐1 receptor agonist via suppressing muscle fibre necroptosis
- (2022) Mari Kamiya et al. Journal of Cachexia Sarcopenia and Muscle
- Amelioration of diabetes‐induced inflammation mediated pyroptosis, sarcopenia, and adverse muscle remodelling by bone morphogenetic protein‐7
- (2021) Chandrakala Aluganti Narasimhulu et al. Journal of Cachexia Sarcopenia and Muscle
- Dulaglutide improves muscle function by attenuating inflammation through OPA-1-TLR-9 signaling in aged mice
- (2021) Phyu Phyu Khin et al. Aging-US
- Effects of GLP-1 receptor agonists on myokine levels and pro-inflammatory cytokines in patients with type 2 diabetes mellitus
- (2021) Valentina Guarnotta et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial
- (2021) Harpreet S Bajaj et al. Lancet Diabetes & Endocrinology
- High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated With Sarcopenia Risk in Hospitalized Renal Cell Carcinoma Patients
- (2021) Qiang Hu et al. Frontiers in Oncology
- Dulaglutide: A Review in Type 2 Diabetes
- (2020) Lesley J. Scott DRUGS
- High neutrophil to lymphocytes ratio is associated with sarcopenia risk in hospitalized cancer patients
- (2020) Thaís C. Borges et al. CLINICAL NUTRITION
- Sarcopenia – Molecular mechanisms and open questions
- (2020) Petra Wiedmer et al. AGEING RESEARCH REVIEWS
- Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention
- (2019) Chun‐wei Li et al. Journal of Cachexia Sarcopenia and Muscle
- Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
- (2019) Yeonhee Hong et al. Journal of Cachexia Sarcopenia and Muscle
- Durability of protective effect of dulaglutide on pancreatic β-cells in diabetic mice: GLP-1 receptor expression is not reduced despite long-term dulaglutide exposure
- (2018) T. Kimura et al. DIABETES & METABOLISM
- Targeting the Incretin/Glucagon System with Triagonists to Treat Diabetes
- (2018) Megan E Capozzi et al. ENDOCRINE REVIEWS
- Sarcopenia: a chronic complication of type 2 diabetes mellitus
- (2018) Heloísa Trierweiler et al. Diabetology & Metabolic Syndrome
- Myokines, physical activity, insulin resistance and autoimmune diseases
- (2018) Buenaventura Brito Díaz et al. IMMUNOLOGY LETTERS
- Circulating irisin levels as a predictive biomarker for sarcopenia: A cross-sectional community-based study
- (2017) Jae Seung Chang et al. Geriatrics & Gerontology International
- Effectiveness of nutritional supplementation on sarcopenia and recovery in hip fracture patients. A multi-centre randomized trial
- (2017) Vincenzo Malafarina et al. MATURITAS
- Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes
- (2016) Jia Liu et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Association between circulating irisin and insulin resistance in non-diabetic adults: A meta-analysis
- (2016) Shanhu Qiu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Different Resistance-Training Regimens Evoked a Similar Increase in Myostatin Inhibitors Expression
- (2015) A. Santos et al. INTERNATIONAL JOURNAL OF SPORTS MEDICINE
- Effects of insulin resistance on skeletal muscle growth and exercise capacity in type 2 diabetic mouse models
- (2014) Joseph E. Ostler et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases
- (2014) Rita Rastogi Kalyani et al. Lancet Diabetes & Endocrinology
- Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: Potential therapeutic targets for cardiac cachexia
- (2013) Tadashi Yoshida et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
- (2012) Pontus Boström et al. NATURE
- Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People
- (2010) A. J. Cruz-Jentoft et al. AGE AND AGEING
- Proteomics Analysis of Human Skeletal Muscle Reveals Novel Abnormalities in Obesity and Type 2 Diabetes
- (2009) H. Hwang et al. DIABETES
- Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes
- (2009) S. W. Park et al. DIABETES CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started